Navigate the future of health and biotechnology in AIstify’s Health & Biotechnology section. From hospitals and life sciences firms to biotech startups and research institutions, we track how AI is reshaping care delivery, drug development, and biomedical research. Coverage spans news, real-world deployments, deals, and policy developments influencing how AI is adopted across healthcare and biotech ecosystems. We focus on clinical decision support, medical imaging, drug discovery, diagnostics, and research automation, alongside regulatory and ethical considerations affecting patient safety and innovation. Our explainers and roundups turn complex updates into clear takeaways, highlighting what’s changing, why it matters now, and how AI is accelerating progress across health and life sciences.
Anthropic is collaborating with Howard Hughes Medical Institute and the Allen Institute to apply its Claude AI model to accelerate biological research and scientific discovery.
Google DeepMind has introduced AlphaGenome, a new AI model designed to analyze long DNA sequences and predict how genetic variations may influence disease development.
Mistral AI released the general availability of Mistral Vibe 2.0, upgrading its terminal-based coding agent as it shifts developer tools from testing to paid enterprise products.
A new assessment by Common Sense Media finds xAI’s Grok chatbot exposes minors to sexual, violent, and unsafe content, with weak age verification and ineffective safety controls.
Climate tech startup Rainbow Weather has raised $5.5 million in seed funding to scale its AI-driven platform for hyper-local, real-time weather forecasting and environmental intelligence.
Utah launches an AI pilot for prescription renewals, letting algorithms handle routine medication management without physicians, highlighting regulatory and safety challenges.
OpenAI now uses age prediction to adjust ChatGPT’s safety settings for teens. Users 18 and older can verify their age to disable extra restrictions.
Bristol Myers Squibb and Microsoft have launched a collaboration to accelerate early detection of lung cancer using AI-powered radiology tools, with a focus on underserved communities.
OpenAI announced it will begin testing ads in ChatGPT for free U.S. users, while paid subscriptions will remain ad-free, marking a potential new revenue stream.
OpenAI has invested in Merge Labs, a brain-computer interface startup founded by CEO Sam Altman, as part of a $250 million seed round valuing the company at $850 million.